about
In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsMammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapiesFrizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growthST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrixShort term ex-vivo expansion of circulating head and neck tumour cells.An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis.Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependentExemplary multiplex bisulfite amplicon data used to demonstrate the utility of Methpat.PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinomaStaurosporine augments EGF-mediated EMT in PMC42-LA cells through actin depolymerisation, focal contact size reduction and Snail1 induction - a model for cross-modulationEpithelial to mesenchymal transition and breast cancer.Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burdenMatrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development.Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.Remodeling of purinergic receptor-mediated Ca2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cellsBeta-actin--an unsuitable internal control for RT-PCR.An MMP13-selective inhibitor delays primary tumor growth and the onset of tumor-associated osteolytic lesions in experimental models of breast cancer.Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas.Contribution of Fibroblast and Mast Cell (Afferent) and Tumor (Efferent) IL-6 Effects within the Tumor MicroenvironmentRegulation of ROCK1 via Notch1 during breast cancer cell migration into dense matrices.High threshold of β1 integrin inhibition required to block collagen I-induced membrane type-1 matrix metalloproteinase (MT1-MMP) activation of matrix metalloproteinase 2 (MMP-2)Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticityThe ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.Editorial: Cellular and Phenotypic Plasticity in Cancer.An optimised direct lysis method for gene expression studies on low cell numbers.LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines.Heterogeneity of miR-10b expression in circulating tumor cellsRole of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesAdipose tissue induction in vivo.Mesenchymal to epithelial transition in development and disease.Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo.Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burdenEpithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm.Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.
P50
Q25257233-F6F0013A-989D-4E0E-89A6-445D28F7C1DBQ26748850-03734733-1513-4EE6-8567-09DCB69454D8Q28074177-21C5B51F-B1D7-4652-B15C-18AFA8F2918EQ28251458-862C719D-BA90-4D1C-82B4-590D468CFCB2Q28504937-7A9518E1-4B28-4919-84AB-705265FD71F1Q30361741-A533CDAB-664B-43E7-AA1F-22253E75C1EAQ30410564-D8CAA6F9-5663-4FCE-8DBF-BB7B38FF160DQ30571243-D672F7BE-BA8F-463A-98DC-11804790BF85Q31028791-BFA557B2-58C6-404D-95C5-6FEA65FB16DAQ33235601-2FEB8E8B-A952-43B6-B21F-D102FB0804A0Q33482559-ADD1466B-9E3B-4618-B166-681612C568D3Q33627118-BF186FAC-AD04-4B9B-B184-3002D353AD99Q33628532-175CE354-38D3-493D-A02D-7A5FD1D381D0Q33706862-3295CCCD-EC17-4E85-A31E-1EF99D0A5699Q33857080-3DC95513-F37E-4576-81D5-CC20B3CC2A44Q33995723-6006B01F-327F-40B9-9454-90365749E8C4Q34104283-54582C5C-3204-4E2F-9E00-4596FA909EE8Q34130512-3BF6A464-A8E2-4AA6-B19C-1FF165932427Q34136905-8A5FA051-90C1-4C5C-A6FC-2092EEB6E4E8Q34153199-9481678C-7B76-494D-AC32-EB9B300288F5Q34268182-1DDAC370-FECE-44F7-9C3C-11E2C34F6B57Q34332877-1C5E0B55-7F13-47A1-9674-8825787F9667Q34442318-7E9CB958-7EDA-4557-AEB7-DD28E8138F81Q35124176-063B3F81-9123-4BA5-806B-C63064E3E32EQ35176165-021039EF-00C8-47A3-A136-C3AE377A7197Q35610049-D140B50A-5D8A-4E17-B21A-27AF4171CE2AQ35797147-7A0F95A3-F8D0-4C19-AB32-E9331594B4A6Q35913063-9D204C8A-C00B-4526-A22B-9C461A7C67DDQ35917630-956CA175-AB2F-460D-8C36-C04E475A95D5Q36023211-0829F712-3806-4A51-880A-B98A5F5D56BCQ36237785-D7D1E3B7-F9A4-426F-9830-3F09E33AA810Q36386428-9E1682CF-E413-4EE8-82AC-34BF5347CAFBQ36660743-D21E3576-195D-49AF-B6BD-5107DADDD891Q36857740-0F772B6B-EF36-497B-9805-F1523D2789EFQ36857862-23BAD6F8-4087-4DAA-A267-F26CC1FCD985Q36891437-1E117962-2EDB-4FC2-8EC1-C93A4E5325B8Q36902961-80EA45D6-00DB-43E5-BAB7-81982AEA6F3BQ36909550-BD756956-C712-41FF-A049-6F3A85ECDF69Q36914343-E7AA41C0-48A3-46BB-90E4-4A645C97277EQ36988816-18901CB2-EDCD-4AC7-9DCD-3F3A1DB9649F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Erik W Thompson
@nl
Erik W Thompson
@sl
Erik W. Thompson
@en
Erik W. Thompson
@es
type
label
Erik W Thompson
@nl
Erik W Thompson
@sl
Erik W. Thompson
@en
Erik W. Thompson
@es
prefLabel
Erik W Thompson
@nl
Erik W Thompson
@sl
Erik W. Thompson
@en
Erik W. Thompson
@es
P1053
A-1425-2009
P106
P1153
7402849735
P21
P31
P3829
P496
0000-0002-9723-4924